Skip to content

Obulytix: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Obulytix

BE 0803.351.624
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€2.7m
2024 · -€1.1m-€1.6m
Equity
€2.2m
2024 · €3.8m-€1.6m
Cash
€1.9m
2024 · €1.5m+€417,676
Balance sheet total
€5.3m
2024 · €5.1m+€193,047

Largest movements

2024 to 2025
Assets
  • Receivables after one year -€435,231

    down €435,231 (-44.3%), from €981,754 to €546,523

  • Cash +€417,676

    up €417,676 (+27.6%), from €1.5m to €1.9m

    mainly Debts after one year (+€2.3m) and Contributions, distributions and other (+€1.1m)

  • Tangible fixed assets +€284,405

    up €284,405 (+128%), from €221,644 to €506,049

    of which Plant, machinery and equipment: +€267,447

Equity and liabilities
  • Profit (loss) carried forward -€2.7m

    down €2.7m (-246%), from -€1.1m to -€3.7m

  • Debts after one year +€2.3m

    new in 2025: €2.3m

  • Contributions +€1.0m

    up €1.0m (+21.4%), from €4.7m to €5.7m

  • Accrued charges and deferred income -€524,431

    down €524,431 (-55.9%), from €938,798 to €414,366

  • Investment grants +€60,903

    up €60,903 (+26.1%), from €233,144 to €294,047

Income statement
  • Gross operating margin -€1.5m

    down €1.5m (-259%), from -€590,450 to -€2.1m

  • Depreciation +€66,231

    up €66,231 (+26.1%), from €254,014 to €320,245

  • Staff costs +€48,017

    up €48,017 (+19.0%), from €252,666 to €300,683

  • Taxes -€37,769

    new in 2025: -€37,769

  • Financial income +€29,646

    up €29,646 (+171%), from €17,311 to €46,957

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€1.1m
Gross operating margin -€1.5m
Staff costs -€48,017
Depreciation -€66,231
Other operating charges -€1,157
Financial income +€29,646
Financial charges -€5,135
Taxes +€37,769
Result 2025 -€2.7m
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€2.3m
Investment -€563,826
Financing +€3.3m
Cash 2024 €1.5m
Net result for the year -€2.7m
Depreciation +€320,245
Receivables after one year +€435,231
Receivables within one year +€38,306
Deferred charges and accrued income -€5,327
Trade debts +€22,049
Tax, wage and social debts +€48,551
Accrued charges and deferred income -€524,431
Investment in fixed assets (net) -€563,826
Debts after one year +€2.3m
Contributions, distributions and other +€1.1m
Cash 2025 €1.9m
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €5,101,630 €5,294,677 +€193,047 +3.8%
Formation expenses 20 €51,052 €39,645 -€11,407 -22.3%
Fixed assets 21/28 €1,972,044 €2,227,032 +€254,988 +12.9%
Intangible fixed assets 21 €1,750,400 €1,720,983 -€29,417 -1.7%
Tangible fixed assets 22/27 €221,644 €506,049 +€284,405 +128%
Plant, machinery and equipment 23 €211,110 €478,557 +€267,447 +127%
Furniture and vehicles 24 €10,534 €27,491 +€16,957 +161%
Current assets 29/58 €3,078,534 €3,028,000 -€50,534 -1.6%
Amounts receivable after more than one year 29 €981,754 €546,523 -€435,231 -44.3%
Other amounts receivable 291 €981,754 €546,523 -€435,231 -44.3%
Amounts receivable within one year 40/41 €580,489 €542,183 -€38,306 -6.6%
Other amounts receivable 41 €580,489 €542,183 -€38,306 -6.6%
Cash at bank and in hand 54/58 €1,513,358 €1,931,033 +€417,676 +27.6%
Deferred charges and accrued income 490/1 €2,933 €8,260 +€5,327 +182%
Total equity and liabilities 10/49 €5,101,630 €5,294,677 +€193,047 +3.8%
Equity 10/15 €3,820,634 €2,217,512 -€1.6m -42.0%
Contributions 10/11 €4,668,644 €5,669,588 +€1.0m +21.4%
Profit (loss) carried forward 14 -€1,081,154 -€3,746,123 -€2.7m -246%
Investment grants 15 €233,144 €294,047 +€60,903 +26.1%
Amounts payable 17/49 €1,280,995 €3,077,165 +€1.8m +140%
Amounts payable after more than one year 17 - €2,250,000 +€2.3m
Financial debts 170/4 - €2,250,000 +€2.3m
Amounts payable within one year 42/48 €342,198 €412,798 +€70,601 +20.6%
Trade debts 44 €315,167 €337,216 +€22,049 +7.0%
Suppliers 440/4 €315,167 €337,216 +€22,049 +7.0%
Taxes, remuneration and social security 45 €27,031 €75,582 +€48,551 +180%
Taxes 450/3 - €8,156 +€8,156
Remuneration and social security 454/9 €27,031 €67,426 +€40,395 +149%
Accrued charges and deferred income 492/3 €938,798 €414,366 -€524,431 -55.9%
Remuneration, social security and pensions 62 €252,666 €300,683 +€48,017 +19.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €254,014 €320,245 +€66,231 +26.1%
Other operating charges 640/8 €150 €1,307 +€1,157 +771%
Gross operating margin 9900 -€590,450 -€2,121,140 -€1.5m -259%
Operating profit (loss) 9901 -€1,097,281 -€2,743,375 -€1.6m -150%
Financial income 75/76B €17,311 €46,957 +€29,646 +171%
Recurring financial income 75 €17,311 €46,957 +€29,646 +171%
Financial charges 65/66B €1,184 €6,319 +€5,135 +434%
Recurring financial charges 65 €1,184 €6,319 +€5,135 +434%
Profit (loss) for the period before taxes 9903 -€1,081,154 -€2,702,738 -€1.6m -150%
Income taxes 67/77 - -€37,769 -€37,769
Profit (loss) for the period 9904 -€1,081,154 -€2,664,969 -€1.6m -146%
Profit (loss) for the period to be appropriated 9905 -€1,081,154 -€2,664,969 -€1.6m -146%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.